Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.7400 (1.01%) ($0.7400 - $0.7400) on Wed. Feb. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.17% (three month average) | RSI | 42 | Latest Price | $0.7400(1.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -2.5% a day on average for past five trading days. | Weekly Trend | ANPC declines -4.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) INDA(46%) IVE(45%) JETS(45%) XHB(45%) XLRE(44%) | Factors Impacting ANPC price | ANPC will decline at least -3.085% in a week (0% probabilities). VIXM(-45%) UUP(-27%) UNG(-27%) USO(-23%) GLD(-23%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.085% (StdDev 6.17%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.81 | 5 Day Moving Average | $0.77(-3.9%) | 10 Day Moving Average | $0.81(-8.64%) | 20 Day Moving Average | $0.81(-8.64%) | To recent high | -58.1% | To recent low | 2.8% | Market Cap | $6m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |